Qvotic Patch
NDC Package 87308-014-01

11-digit billing NDC: 87308001401

Package Information

Qvotic (lidocaine pain relief patch) patches is adults and children 12 years and older:Clean and dry the affected area Remove the protective film from the patch Apply gel side directly to the painful area Use 1 patch at a time, up to 3‑4 times daily Each patch can be worn for up to 8‑12 hours Discard after single use For first‑time users: limit initial use to 4‑6 hours to test skin tolerance to menthol Children under 12 years: Ask a doctor before use. This formulation utilizes a patch delivery system. Marketed by Shenzhen Hengdasheng Technology Co., Ltd, this product is identified by NDC 87308-014 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
87308-014-01
Package Description
8 U in 1 BOX
Product Code
11-Digit Billing Format
87308001401

Clinical Specifications

Proprietary Name
Qvotic
Non-Proprietary Name
Lidocaine Pain Relief Patch
Substance Name
Lidocaine; Menthol
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Adults and children 12 years and older:Clean and dry the affected area Remove the protective film from the patch Apply gel side directly to the painful area Use 1 patch at a time, up to 3‑4 times daily Each patch can be worn for up to 8‑12 hours Discard after single use For first‑time users: limit initial use to 4‑6 hours to test skin tolerance to menthol Children under 12 years: Ask a doctor before use

Regulatory & Marketing

Labeler Name
Shenzhen Hengdasheng Technology Co., Ltd
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-22-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87308-014-01 identifies a specific commercial package of 8 u in 1 box of Qvotic, a human over the counter drug labeled by Shenzhen Hengdasheng Technology Co., Ltd. This patch is formulated for topical use and contains lidocaine; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shenzhen Hengdasheng Technology Co., Ltd on September 22, 2026. The current certification is valid through December 31, 2027.

How is this Shenzhen Hengdasheng Technology Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87308001401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87308-014-01
11-Digit CMS (5-4-2)
87308-0014-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.